Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 1
1950 3
1951 1
1952 1
1953 3
1955 2
1957 2
1959 3
1960 5
1962 1
1963 1
1964 1
1965 1
1966 2
1967 4
1968 1
1969 2
1970 2
1971 2
1972 3
1973 1
1974 2
1975 2
1976 3
1977 1
1979 1
1980 2
1981 2
1982 3
1983 3
1984 2
1986 2
1987 4
1988 3
1989 1
1990 1
1991 3
1992 3
1993 2
1994 2
1995 3
1996 6
1997 5
1998 1
1999 2
2000 3
2001 1
2002 1
2003 1
2004 1
2005 2
2006 2
2007 2
2008 5
2009 8
2010 7
2011 4
2012 7
2013 10
2014 4
2015 6
2016 4
2017 3
2018 3
2019 6
2020 5
2021 15
2022 13
2023 13
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Vogt-Koyanagi-Harada disease.
Street D, Sivaguru A, Sreekantam S, Mollan SP. Street D, et al. Pract Neurol. 2019 Aug;19(4):364-367. doi: 10.1136/practneurol-2018-002152. Epub 2019 Mar 19. Pract Neurol. 2019. PMID: 30890584
Authors' reply.
Larcombe SJ, Street D, Wright B. Larcombe SJ, et al. Among authors: street d. J R Coll Physicians Edinb. 2021 Dec;51(4):424-427. doi: 10.4997/JRCPE.2021.426. J R Coll Physicians Edinb. 2021. PMID: 34882151 No abstract available.
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Street D, Jabbari E, Costantini A, Jones PS, Holland N, Rittman T, Jensen MT, Chelban V, Goh YY, Guo T, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Houlden H, Morris H, Rowe JB. Street D, et al. Brain. 2023 Aug 1;146(8):3232-3242. doi: 10.1093/brain/awad105. Brain. 2023. PMID: 36975168 Free PMC article.
Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.
Malpetti M, Swann P, Tsvetanov KA, Chouliaras L, Strauss A, Chikaura T, Murley AG, Ashton NJ, Barker P, Jones PS, Fryer TD, Hong YT, Cope TE, Savulich G, Street D, Bevan-Jones WR, Rittman T, Blennow K, Zetterberg H, Aigbirhio FI, O'Brien JT, Rowe JB. Malpetti M, et al. Among authors: street d. Brain. 2024 Aug 19:awae269. doi: 10.1093/brain/awae269. Online ahead of print. Brain. 2024. PMID: 39155063 Free PMC article.
GABAergic cortical network physiology in frontotemporal lobar degeneration.
Adams NE, Hughes LE, Rouse MA, Phillips HN, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Friston K, Rowe JB. Adams NE, et al. Among authors: street d. Brain. 2021 Aug 17;144(7):2135-2145. doi: 10.1093/brain/awab097. Brain. 2021. PMID: 33710299 Free PMC article. Clinical Trial.
Structural correlates of survival in progressive supranuclear palsy.
Street D, Bevan-Jones WR, Malpetti M, Jones PS, Passamonti L, Ghosh BC, Rittman T, Coyle-Gilchrist IT, Allinson K, Dawson CE, Rowe JB. Street D, et al. Parkinsonism Relat Disord. 2023 Nov;116:105866. doi: 10.1016/j.parkreldis.2023.105866. Epub 2023 Oct 2. Parkinsonism Relat Disord. 2023. PMID: 37804622 Free PMC article.
Neurophysiological consequences of synapse loss in progressive supranuclear palsy.
Adams NE, Jafarian A, Perry A, Rouse MA, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Hughes LE, Friston KJ, Rowe JB. Adams NE, et al. Among authors: street d. Brain. 2023 Jun 1;146(6):2584-2594. doi: 10.1093/brain/awac471. Brain. 2023. PMID: 36514918 Free PMC article.
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Lee JM, Brady MF, Miller A, Moore RG, MacKay H, McNally L, Lea J, Street D, Lheureux S, McDonald ME, Duska LR, Cantuaria G, Kavecansky J, Leath CA 3rd, Powell M, Cadungog MG, Rose PG, Kim YM, Huang HQ, Provencher M, Wenzel LB, Bookman MA, Kohn EC, Secord AA. Lee JM, et al. Among authors: street d. J Clin Oncol. 2024 Dec 20;42(36):4305-4316. doi: 10.1200/JCO.24.00683. Epub 2024 Oct 3. J Clin Oncol. 2024. PMID: 39361946 Clinical Trial.
219 results